Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL), a pharmaceutical company developing cannabinoid pharmaceutical medicines and psychedelic therapies for unmet medical needs, will feature as a presenting company at the H.C. Wainwright 25th Annual Global Investment Conference on September 11-13, 2023.
CEO and managing director Joel Latham will provide an overview of the company during the presentation, and IHL will take one-on-one meetings virtually.
If you are an institutional investor and would like to listen to the company’s presentation or request a one-on-one meeting, you can do so here.